Characteristic of both chronic wounds and acute wounds that fail to heal are excessive leukocytosis and reduced matrix deposition. Estrogen is a major regulator of wound repair that can reverse age-related impaired wound healing in human and animal models, characterized by a dampened inflammatory response and increased matrix deposited at the wound site. Macrophage migration inhibitory factor (MIF) is a candidate proinflammatory cytokine involved in the hormonal regulation of inflammation. We demonstrate that MIF is upregulated in a distinct spatial and temporal pattern during wound healing and its expression is markedly elevated in wounds of estrogen-deficient mice as compared with intact animals. Wound-healing studies in mice rendered null for the MIF gene have demonstrated that in the absence of MIF, the excessive inflammation and delayed-healing phenotype associated with reduced estrogen is reversed. Moreover, in vitro assays have shown a striking estrogen-mediated decrease in MIF production by activated murine macrophages, a process involving the estrogen receptor. We suggest that estrogen inhibits the local inflammatory response by downregulating MIF, suggesting a specific target for future therapeutic intervention in impaired wound-healing states.
Gillian S. Ashcroft, Stuart J. Mills, KeJian Lei, Linda Gibbons, Moon-Jin Jeong, Marisu Taniguchi, Matthew Burow, Michael A. Horan, Sharon M. Wahl, Toshinori Nakayama
Title and authors | Publication | Year |
---|---|---|
Local macrophage proliferation, rather than recruitment from the blood, is a signature of Th2 inflammation*
SJ Jenkins, D Ruckerl, PC Cook, LH Jones, FD Finkelman, N Rooijen, AS MacDonald, JE Allen |
Science (New York, N.Y.) | 2011 |
Modulatory effect of a complex fraction derived from colostrum on fibroblast contractibility and consequences on repair tissue
CJ Doillon, F Lehance, LJ Bordeleau, MP Laplante-Campbell, R Drouin |
International Wound Journal | 2011 |
Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive Pathogens
JE Allen, TA Wynn, HD Madhani |
PLoS pathogens | 2011 |
Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivoevidence
TD Lund, C Blake, L Bu, AN Hamaker, ED Lephart |
Reproductive Biology and Endocrinology | 2011 |